Talaris Therapeutics is a late-clinical stage cell therapy company that is developing an innovative method of allogeneic stem cell transplantation that we believe can potentially transform the standard of care in solid organ transplantation, certain severe autoimmune diseases, and certain severe non-malignant blood, immune, and metabolic disorders. In the organ transplant setting, which is our initial focus, we believe that our proprietary therapeutic approach could prevent organ rejection without the consequences associated with chronic immunosuppression.
Hope Week 2022 Exhibit Booth - Talaris Therapeutics
